Recent investigations suggest that Gymnema's effects on insulin secretion may involve incretin pathways, potentially including GLP-1 [14]
GLP-1s generally have a hefty price tag and can start at $800 or more a month, and most private insurers dont cover these medications for weight loss
Safety, side effects, and clinical oversight All three platforms prescribe medications in the GLP-1 receptor agonist class (and tirzepatide, a GIP/GLP-1 dual agonist)
Losing too much muscle can make patients weaker, more fatigued, and more likely to regain weight later
Graphical Abstract Similar content being viewed by others Introduction Chemotherapy-induced cognitive impairment (CICI), termed chemobrain or chemofog, refers to the state of extended cognitive impairment resulting from the administration of a variety of chemotherapeutic agents including doxorubicin, cyclophosphamide, 5-fluorouracil, and methotrexate (Christie et al
Metformin reduces lipid accumulation in macrophages by inhibiting foxo1-mediated transcription of fatty acid-binding protein 4